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Abstract
Background: The roles of the tuberculin skin test (TST) and QuantiFERON
®-TB Gold In-Tube assay (QFT-IT) in the
diagnosis of active tuberculosis (TB) are not clear in young adults. We evaluated the diagnostic accuracy of the TST
and QFT-IT in smear-negative TB among young adults with no underlying disease.
Methods: We prospectively enrolled 166 young participants 20-29 years of age with suspected active TB in a
military hospital of South Korea. The TST and QFT-IT were performed for all participants.
Results: Of the 143 patients included in the analysis, active TB was diagnosed in 100 (69.9%). There were 141 male
patients, none of whom had immunosuppressive disease. The sensitivity, specificity, positive predictive value (PPV),
and negative predictive value (NPV) of TST were 94% (95% CI, 87-98%), 88% (95% CI, 74-96%), 95% (95% CI, 88-
98%), and 86% (95% CI, 72-94%), respectively. The sensitivity, specificity, PPV, and NPV of the QFT-IT were 93% (95%
CI, 86-97%), 95% (95% CI, 81-99%), 98% (95% CI, 92-99%), and 84% (95% CI, 69-93%), respectively. No significant
differences were found between the TST and QFT-IT in any statistic.
Conclusions: Both the TST and QFT-IT showed high sensitivity and specificity in differentiating active TB from
other diseases. The diagnostic accuracy of these two tests did not differ significantly when applied to this clinical
population of young, immunocompetent adults in whom neonatal BCG vaccination was common, there was no
history of previous TB and in whom suspicion of TB was high.
Trial registration: ClinicalTrials.gov: NCT00982969
Background
Tuberculosis (TB) is an important public health problem
worldwide. In 2007, there were 9.27 million cases of TB,
and 1.3 million deaths occurred among HIV-negative
TB cases [1]. South Korea has an intermediate TB bur-
den; the incidence of new cases is 90 per 100 000 people
per year despite an intensive effort for disease control
[2]. A prompt and accurate diagnosis is critical for effec-
tive control and management of TB, but conventional
diagnostic methods have their limitations. Completion
of mycobacteria culture takes 3-8 weeks on solid
medium and 7-21 days in liquid medium [3,4]. The sen-
sitivity of acid-fast bacilli (AFB) smears is low [3]. The
polymerase chain reaction test is often used for rapid
microbiological diagnosis of TB, but its sensitivity for
smear-negative respiratory samples ranges from 48 to
53% [3,5,6].
The tuberculin skin test (TST) and whole-blood inter-
feron-g release assay (IGRA) have been employed for diag-
nosing latent TB infection (LTBI), but they have also been
investigated for their usefulness in the diagnosis of active
TB. Although the IGRA is considered to be more useful
than the TST in differentiating active TB [7-9], it has not
been shown to be adequate for use as a rule-out test for
active TB, with a pooled sensitivity and specificity of 80%
[10]. However, in some populations, a higher sensitivity
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which suggests that the IGRA may be utilized in selected
populations. The TST has low specificity in Bacille Calm-
ette-Guérin (BCG)-vaccinated populations [13,14] and
several disadvantages compared with IGRA, but it is inex-
pensive and simple, facilitating its use in the community
and in resource-limited settings [15].
Young adults have some distinctive characteristics.
They are immunologically active and have a shorter dura-
tion of unknown TB exposure than do elderly people.
Furthermore, nontuberculous mycobacteria (NTM) sen-
sitization is not prevalent in this group, and more than
10 years have passed since their BCG vaccination at
birth. The clinical utility of the TST and IGRA may differ
by age, and the rates of positive TST results were found
to be significantly higher in younger than in elderly
patients (70% vs. 27%, respectively) [8]. We evaluated the
diagnostic accuracy of the TST and IGRA in the diagno-
sis of smear-negative TB in young and immunocompe-
tent adults in the Korean military, where the IGRA is not
usually available.
Methods
Participants and data collection
We prospectively enrolled all individuals 20 to 29 years
old who were highly suspect for TB at the Armed
Forces Capital Hospital, a central military referral hospi-
tal in Korea, between May 2008 and September 2009.
Subjects who had a previous history of TB or who had
taken anti-TB medication for more than 1 month before
the visit were excluded. After giving informed consent,
each participant was asked to complete a questionnaire
about his or her demographics, previous history of TB,
smoking status, and other factors. In addition, the TST
and QuantiFERON
®-TB Gold In-tube assay (QFT-IT;
Celletis Ltd., Victoria, Australia) were performed on all
participants. This study was reviewed and approved by
the Institutional Review Board of the Armed Forces
Medical Command.
Tuberculin skin test
The TST was performed after blood sampling for QFT-
IT by trained personnel following standard procedures.
For this test, 0.1 mL (2 TU) purified protein derivate
(RT23; Statens Serum Institute, Copenhagen, Denmark)
was injected intradermally into the inner side of the left
forearm by three experienced nurses. Transverse indura-
tion at the TST site was measured in mm after 48-72 h
by an experienced physician (Dr. S. W. Lee). We defined
a positive test as an induration of ≥10 mm [16].
Interferon-gamma release assay
QFT-IT, a type of IGRA, was performed according to
the manufacturer’s instructions. Blood samples were
collected in three special tubes: one coated with the Myco-
bacterium tuberculosis (MTB)-specific peptides ESAT-6,
CFP-10, and TB 7.7 (Rv2654, only peptide 4); one with
mitogen as a positive control; and one without antigen as
a negative control. Within 8 h of blood sampling, tubes
were incubated for 24 h at 37°C, followed by centrifuga-
tion and cold storage until testing, as specified by the
manufacturer. The concentration of IFN-g in plasma was
measured using a commercial QFT-IT ELISA. The test
result was determined as negative, intermediate, or posi-
tive (cutoff at 0.35 IU/mL and ≥25% of the nil control) by
the manufacturer’s software. The doctors in charge were
blinded to the QFT-IT result prior to diagnosis.
Definitions and diagnoses
Final diagnoses were made on the basis of all clinical,
radiologic, microbiologic, and pathologic information.
Active TB cases were defined as follows:
Active pulmonary TB
Active pulmonary TB was defined if: (i) MTB was cul-
tured from sputum, bronchial specimens or (ii) patient
data met the definition of a clinical case of TB, according
to the WHO [17]. For clinical cases of TB, radiographic
lesions compatible with active TB upon HRCT were
mandatory. Active pulmonary TB was defined as the pre-
sence of cavities, branching linear opacity, or multiple
non-calcified nodules upon HRCT. However, lesions that
appeared mainly as calcified nodules or fibrotic bands
were excluded from the diagnosis of active TB [17-19]. In
participants with lesions that suggested active TB, but
who did not have positive acid-fast smears or culture of
M. tuberculosis, broad-spectrum antibiotics (combination
of a third-generation cephalosporin and a macrolide)
were prescribed for 1 week. If the lesions on chest X-ray
(CXR) or HRCT showed definite improvement, a diagno-
sis of active TB was excluded.
Pleural TB
Pleural TB was diagnosed if: (i) M. tuberculosis was
detected in the culture of pleural fluid or tissue, or (ii)
exudative pleural effusion showed lymphocyte predomi-
nance, negative cytology, low carcinoembryonic antigen
(< 5 ng/ml) and high adenosine deaminase (≥50 IU/l).
Lymph node TB
Lymph node TB was diagnosed if one of the following
criteria: (i) detection of M. tuberculosis in a culture or of
lymph node tissue, (ii) pathological changes consistent
with TB or, (iii) positive real-time polymerase chain reac-
tion for M. tuberculosis in the tissue of lymph nodes con-
firmed by commercialized kit (COBAS
® TaqMan
® MTB
t e s t ,R o c h e ,W e s tS u s s e x ,U K )a n dad i s t i n c tc l i n i c a l
response to a anti-TB medication.
The diagnosis of other types of extrapulmonary TB was
made prospectively on the basis of clinical manifestation
consistent with TB and cultures of M. tuberculosis.
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definite diagnosis had been made.
Pneumonia
Pneumonia was defined as a new pulmonary infiltrate
associated with at least one of the following factors: a
new or increased cough, abnormal temperature (<35.8°C
or >37.8°C), or an abnormal leukocyte count (leukocyto-
sis, leukopenia, or the presence of immature neutro-
phils). We confirmed the resolution of the pulmonary
infiltrate after administrating broad-spectrum antibiotics.
Pulmonary paragonimiasis
Pulmonary paragonimiasis was diagnosed by detection of
parasite ova in sputum and/or stools. In egg-negative
cases with peripheral eosinophilia and suspicious radiolo-
gic findings including patchy densities, cavities, pleural
effusions, and ring shadows, elevated serum specific IgG
antibody concentration for Paragonimus westermani
helped to confirm the diagnosis.
Empyema
Empyema refers to a grossly purulent pleural effusion
associated with pneumonia.
Statistical methods
Using active TB as the gold standard, we classified the
results of TST and QFT-IT as true positive (TP), false
negative (FN), false positive (FP), or true negative (TN).
The sensitivity (TP/[TP + FN]), specificity (TN/[TN +
FP]), positive predictive value (PPV) (TP/[TP + FP]), nega-
tive predictive value (NPV) (TN/[TN + FN]), positive like-
lihood ratio (LR+) (sensitivity/[1 - specificity]), and
negative likelihood ratio (LR-) ([1 - sensitivity]/specificity)
were calculated for each diagnostic test. The area under
the curve (AUC) of the receiver operating characteristic
curve (ROC) was calculated to measure the overall accu-
racy of the test. Ninety-five percent confidence intervals
(CIs) were estimated according to the binominal distribu-
tion. A c
2 test was used to compare the positive p-values,
for which <0.05 was considered significant. Concordance
between test results from the TST and QFT-IT was
assessed using  coefficients [20]. Statistical analyses were
performed using STATA 10.1 software (STATA Corp.,
College Station, TX, USA).
Results
Baseline characteristics of the study populations
A total of 166 patients were recruited, 23 of whom were
excluded from the final analysis because their sputum
smear results were positive. All patients were HIV negative,
and no patient had risk factors for immunosuppression. A
BCG scar was present in 102 patients (71.3%). Active TB
was diagnosed in 100 (69.9%) patients. Forty-three patients
(30.1%) were classified as non-TB cases. Pneumonia was
the most common diagnosis among non-TB cases. Com-
pared to non-TB cases, TB cases had a significantly higher
percentage of patients with sputum. Concerning the
laboratory data, TB cases had a significantly lower peak
body temperature and serum CRP concentration (Table 1).
Five patients were not able to expectorate sputum.
One of the five patients had MTB isolated in his bron-
chial washing fluid. Three of the five presented with cer-
vical lymphadenopathy (LAP); one was diagnosed with
malignant lymphoma on pathologic exam, and the other
two were diagnosed with reactive LAP because the
enlarged lymph nodes became smaller with resolution of
symptoms during follow-up. The last of the five patients
was diagnosed with paragonimiasis; this patient had a
peripheral eosinophilia, eosinophil-dominant pleural
effusion, and elevated serum-specific IgG antibody con-
centration for P. westermani. MTB was not isolated in
the AFB culture of his pleural fluid.
Table 1 Baseline characteristics of the study population
Characteristics TB
(n = 100)
Non-TB
(n = 43)
P value
Age, median(range), yrs 22(20-30) 21(20-26) 0.02
Male Gender 98(98) 43(100) 0.87
Smoking History
Non-smoker 50(50.0) 22(51.2) 0.46
Ex-smoker 3(3.0) 4(9.3)
Current smoker 47(47.0) 17(39.5)
BCG scar present 70(70.0) 32(74.4) 0.59
Sputum AFB smear
Negative 99(99.0) 39(90.7) <0.05
Non-productive 1(1.0)* 4(9.3)
†
Symptom present
Cough 52(52.0) 29(67.4) 0.09
Sputum 39(39.0) 28(65.1) <0.01
Hemoptysis 10(10.0) 8(18.6) 0.15
Peak BT(°C), mean ± SD 37.1 ± 0.8 37.6 ± 1.1 0.01
WBC(×10
3cells/uL), mean ± SD 6.89 ± 1.85 8.33 ± 5.21 0.09
CRP(mg/dL), mean ± SD 2.02 ± 3.32 6.35 ± 8.98 <0.01
Final Diagnosis
Culture-positive
pulmonary TB
41(41.0)
Clinical pulmonary TB 35(35.0)
Extrapulmonary TB 24(24.0)
Pleural TB 19(19.0)
Lymph node TB 2(2.0)
Other site 3(3.0)
Pneumonia 30(69.8)
Paragonimiasis 3(7.0)
Empyema 2(4.7)
Other diagnoses 8(18.6)
Data are no.(%) of patients, unless otherwise indicated.
BCG, Bacille Calmette-Guerin; BT, body temperature; WBC, white blood cell;
CRP, C-reactive protein; AFB, acid-fast bacilli; TB, tuberculosis.
* Mycobacterium tuberculosis was isolated on bronchial washing fluid.
† Four subjects include two with reactive lymphadenopathy, one with
malignant lymphoma and one with paragonimiasis.
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Of 142 patients with available TST results, the results
were positive in 98 (69.0%), 93 of whom were diagnosed
with active TB; the results were negative in 44 (31.0%)
patients, six of whom was diagnosed with active TB. Of
the 143 patients who underwent QFT-IT tests, five
patients (3.5%) had an indeterminate result. The results
of QFT-IT were positive in 95 patients (66.4%), 93 of
whom were diagnosed with active TB; the results were
negative in 43 (30.1%), seven of whom were diagnosed
with active TB (Table 2).
The TST sensitivity for the diagnosis of active TB was
94% (95% CI, 87-98%), and the specificity was 88% (95%
CI, 74-96%). The QFT-IT sensitivity was 93% (95% CI,
86-97%), and the specificity was 95% (95% CI, 81-99%).
None of the four statistics was significantly different
between the TST and QFT-IT, revealing excellent agree-
ment between the two assays ( = 0.83, with exclusion
of five indeterminate results in QFT-IT, P <0 . 0 0 1 ,
Table 3).
Clinical findings of the participants with indeterminate
QFT-IT results
Five patients showed indeterminate QFT-IT results; all
were non-TB cases. Four patients had bacterial pneumo-
nia, and one patient had empyema. One patient showed
severe lymphocytopenia (Patient 2), and three patients
(Patients 1-3) showed low serum albumin concentra-
tions (Table 4).
Discussion
Our study showed that both the TST and QFT-IT had
high sensitivity and specificity in the diagnosis of active
TB among young military personnel in South Korea.
The specificity for both tests was higher than that pre-
viously reported in South Korea [7,21], and that of the
TST (88%) was slightly lower than that of the QFT-IT
(95%); however, the difference was not statistically sig-
nificant (p = 0.53).
There are two possible explanations for the higher sen-
sitivities and specificities compared with those in pre-
vious reports. First, false-positive TST reactions due to
BCG vaccination in infancy become minimal in young
adults. In a review of 24 published studies regarding the
effect of BCG vaccination on TST, only 1% of subjects
vaccinated as infants were TST-positive if tested ≥10
years after BCG [15]. The prevalence of a positive TST
has also been correlated with the number of BCG scars, a
proxy for older age when last vaccinated [22,23]. BCG
revaccination in individuals 12 to 13 years of age was dis-
continued in South Korea in 1997 based on a WHO
recommendation [24]. Of the 143 patients enrolled in
this study, only two patients had two BCG scars. Second,
this study enrolled young and immune-competent adults.
The median age of previous studies that reported lower
specificities was 55 years [7]. The sensitivities of the
IGRA are known to decrease significantly with older age
[8], HIV infection [25], and chronic renal failure [26].
Previous studies in which the IGRA had a higher sensi-
tivity than that of the TST [14,27] suggest that the IGRA
may be more useful in the diagnostic exclusion of active
TB. In a recent meta-analysis of IGRA for detecting active
TB, the pooled sensitivity of the QFT-IT (81%; 95% CI, 78-
83%) among definitively confirmed TB cases was higher
than that of the TST (70%; 95% CI, 67-72%) [13]. However,
few studies have compared the performances of the TST
and IGRA in young adults. In a Japanese study on the clini-
cal utility of the QFT-2G test for elderly patients with
active TB, the rates of positiveT S Tr e s u l t sw e r es i g n i f i -
cantly higher in younger patients (27% vs. 70%) [8]. We
assumed that the sensitivity of the TST would be compar-
able to that of the QFT-IT in young, previously healthy
adults, and the sensitivity of the TST (94%) and QFT-IT
(93%) showed no statistically significant difference (p =
0.79) in this study. However, considering the difference in
positive likelihood ratio between TST and QFT-IT(8.1 vs
17.7), TST is expected to be less useful than QFT-IT for
ruling in active TB as the post-test probability falls below
50%.
Indeterminate QFT-2G results were more common in
patients receiving immunosuppressive therapy, especially
those with lymphocytopenia [28]. One patient had
Table 2 The results of TST and QFT-IT among active TB
and non-TB disease
TST (n = 142*) Total QFT-IT (n = 138
†) Total
positive negative positive negative
TB 93 6 99 93 7 100
Non-TB 5 38 43 2 36 38
Total 98 44 142 95 43 138
TB, tuberculosis; TST, tuberculin skin test; QFT-IT, QuantiFERON
® TB Gold In-
Tube assay.
*TST result was not available in one TB patient.
† QFT-IT results were indeterminate in five non-TB patients.
Table 3 Diagnostic accuracy of TST and QFT-IT in the
diagnosis of active TB
TST (n = 142) QFT-IT (n = 138) P value
Sensitivity, % (95% CI) 94 (87-98) 93 (86-97) 0.79
Specificity, % (95% CI) 88 (74-96) 95 (81-99) 0.53
PPV, % (95% CI) 95 (88-98) 98 (92-99) 0.47
NPV, % (95% CI) 86 (72-94) 84 (69-93) 0.73
LR+ (95% CI) 8.1 (3.5-18.4) 17.7(4.6-68.2)
LR- (95% CI) 0.07 (0.03-0.15) 0.07 (0.04-0.15)
AUC (95% CI) 0.91 (0.85-0.97) 0.94 (0.89-0.99)
PPV, positive predictive value; NPV, negative predictive value, LR+, positive
likelihood ratio; LR-, negative likelihood ratio; AUC, area under curve; TST,
tuberculin skin test; QFT-IT, QuantiFERON
® TB Gold In-Tube assay
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Patient
No.
QFT-IT result Age BCG
scar
WBC
(cells/uL)
Lymphocyte count
(cells/uL)
Serum total Protein
(mg/dL)
Serum albumin
(mg/dL)
TST
(mm)
AFB Smear/Culture in sputum
examination
Radiologic
finding
Diagnosis
1 Indeterminate 22 Yes 10,390 1,039 6.4 3.3 0 -/- Multifocal
consolidations
Pneumonia
2 Indeterminate 21 Yes 28,180 366 5.9 3.2 0 -/- LLL consolidation Pneumonia
3 Indeterminate 20 Yes 7,110 683 5.3 2.8 0 -/- Multifocal
consolidations
Pneumonia
4 Indeterminate 23 Yes 10,620 1,296 7.6 4.2 0 -/- RML, RLL
consolidations
Empyema
5 Indeterminate 20 Yes 9,460 1,296 8.1 4.2 0 -/- RLL consolidation Pneumonia
QFT-IT, QuantiFERON
® TB Gold In-Tube assay; BCG, Bacille Calmette-Guerin; WBC, white blood cells; TST, tuberculin skin test; AFB, acid-fast bacilli; RML, right middle lobe; LUL, left upper lobe; LLL, left lower lobe;
RLL, right lower lobe.
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7severe lymphocytopenia. Malnutrition may lower the
sensitivity of the IGRA [14]. Three patients showed low
serum albumin concentrations. The serum albumin con-
centration is a marker of nutritional status; these
patients may have been suffering from malnutrition,
which could explain these indeterminate results.
We used 10 mm as the TST cutoff considering the
communal setting, relatively higher incidence in South
K o r e at h a ni no t h e rd e v e l o p e dc o u n t r i e s ,a n dl a r g e
number of subjects with BCG scars (71.3%). In the case
of residents in high-risk congregate settings and recent
immigrants from high-prevalence countries, ≥10 mm of
induration is recommended as the criterion for a posi-
tive TST [16,29]. Most tuberculin skin reactions affected
by BCG are less than 10 mm [30]. Although this can
affect the diagnostic accuracy of the TST, the sensitivity
and specificity were 97% (95% CI, 91-99%) and 88%
(95% CI, 74-96%), respectively, when we applied 5 mm
as the TST cutoff. Therefore, the change would be mini-
mal if a cutoff of 5 mm were used in this study.
There are a few limitations in this study. First, the study
population and clinical setting in this study were quite
selective, and it is difficult to generalize this result to other
situations. However, the study demonstrates the possibility
that the TST and QFT-IT can play roles in determining
TB disease for selected population. Second, comparisons
with other age groups were not performed, and the diag-
nostic accuracy was evaluated for only one group. Third,
the influence of BCG vaccination could not be evaluated
because we did not know the accurate age of BCG vacci-
nation of the subjects. However, school-age revaccination
was abandoned in Korea 15 years ago when these subjects
were 5 to 15 years old. For the past 15 years, BCG vaccina-
tion has been performed only at birth. Therefore, we can
estimate that most subjects receive BCG vaccination at
birth and that the effect on the TST is minimal.
Conclusions
Both the TST and QFT-IT showed high diagnostic accu-
racy for discriminating active TB from other pulmonary
diseases. The diagnostic accuracy of these two tests did
not differ significantly when applied to this clinical popu-
lation of young, immunocompetent adults in whom neo-
natal BCG vaccination was common, there was no
history of previous TB and in whom suspicion of TB was
high. Therefore, in some selected populations, the TST
and IGRA may be utilized as reliable aids to diagnose
active TB, although the diagnosis should be confirmed by
microbiologic, radiologic, and clinical methods.
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